Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:March 28, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:March 28, 2023Recruiting
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:March 4, 2022Not yet recruiting
Condition(s):Hodgkin LymphomaLast Updated:April 1, 2019Recruiting
Condition(s):Hodgkin LymphomaLast Updated:August 12, 2020Recruiting
Condition(s):Myeloid Malignancy; Acute Myeloid LeukemiaLast Updated:November 13, 2023Not yet recruiting
Condition(s):PTCL; CTCLLast Updated:January 6, 2023Recruiting
Condition(s):Systemic Mastocytosis With an Associated Hematologic NeoplasmLast Updated:March 26, 2024Recruiting
Condition(s):Myeloproliferative NeoplasmLast Updated:April 5, 2023Recruiting
Condition(s):Chronic Myelomonocytic Leukemia; Chronic Myelomonocytic Leukemia-1; Chronic Myelomonocytic Leukemia-2; Myelodysplastic/Myeloproliferative NeoplasmLast Updated:March 27, 2024Recruiting
Condition(s):Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Patient PreferenceLast Updated:March 15, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.